Marta Agudo Barriuso-rekin lankidetzan egindako argitalpenak (12)

2024

  1. Effect of the transplantation type on the neuroprotective properties of mesenchymal stromal cells

    Acta Ophthalmologica, Vol. 102, Núm. S279

  2. Interplay between mesenchymal stromal cells and the immune system after transplantation: implications for advanced cell therapy in the retina

    Neural Regeneration Research, Vol. 19, Núm. 3, pp. 542-547

  3. Retinal response to systemic inflammation differs between sexes and neurons

    Frontiers in Immunology, Vol. 15

2023

  1. Analysis of the neuroprotective effect of mesenchymal stromal cells in neuronal death caused by acute systemic inflammation.

    8th International Congress of Research in Retina and Vision (SIREV).

2022

  1. Effect of systemic immunosuppression and BM‐MSC allotransplantation in retinal functionality and RGC population

    Acta Ophthalmologica, Vol. 100, Núm. S267

  2. Immune recognition of syngeneic, allogeneic and xenogeneic stromal cell transplants in healthy retinas

    Stem Cell Research and Therapy, Vol. 13, Núm. 1

2021

  1. Neuroprotection and Axonal Regeneration Induced by Bone Marrow Mesenchymal Stromal Cells Depend on the Type of Transplant

    Frontiers in Cell and Developmental Biology, Vol. 9

2019

  1. Mesenchymal stromal cell therapy for damaged retinal ganglion cells, is gold all that glitters?

    Neural Regeneration Research, Vol. 14, Núm. 11, pp. 1851-1857

2018

  1. Human Wharton’s jelly mesenchymal stem cells protect axotomized rat retinal ganglion cells via secretion of anti-inflammatory and neurotrophic factors

    Scientific Reports, Vol. 8, Núm. 1

2017

  1. Neuroprotective effect of mesenchymal stem cells isolated from the Wharton’s jelly of the human umbilical cord

    Investigative Ophthalmology & Visual Science

2016

  1. Neuroprotective effect of mesenchymal stem cells isolated from the Wharton’s jelly of the umbilical cord.

    Congreso de la European Society of Gene & Cell Therapy y Sociedad Italiana de Terapia Génica y Celular

  2. Topical treatment with bromfenac reduces retinal gliosis and inflammation after optic nerve crush

    Investigative Ophthalmology and Visual Science, Vol. 57, Núm. 14, pp. 6098-6106